Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...

U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...

An entrenched and escalating drug market is creating chronic public safety issues in Seattle’s University District, according ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

The researchers found that drug seizures in San Francisco were associated with a substantial increase in fatal opioid ...

The National Agency for Food and Drug Administration and Control (NAFDAC) on Friday destroyed fake, counterfeit and ...